Impact of Partial Body Shielding from Very High Dose Rates on Untargeted Metabolomics in Biodosimetry

• Evan L. Pannkuk,
• Evagelia C. Laiakis,
• Guy Garty,
• Sunil Bansal,
• Meth M. Jayatilake,
• Yuewen Tan,
• Brian Ponnaiya,
• Xuefeng Wu,
• Sally A. Amundson,
• David J. Brenner,
• Albert J. Fornace

Affiliations

Evan L. Pannkuk

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, United States

Evagelia C. Laiakis

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, United States

Guy Garty

Radiological Research Accelerator Facility, Columbia University, Irvington, New York, United States

Sunil Bansal

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, United States

Meth M. Jayatilake

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, United States

Yuewen Tan

Radiological Research Accelerator Facility, Columbia University, Irvington, New York, United States

Brian Ponnaiya

Radiological Research Accelerator Facility, Columbia University, Irvington, New York, United States

Xuefeng Wu

Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States

Sally A. Amundson

Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States

David J. Brenner

Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States

Albert J. Fornace

Department of Oncology, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, United States